Back
Denali Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9
DNLI
Denali Therapeutics
Last Price:
$12.80
Seasonality Move:
12.15%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and DNLI is experiencing slight selling pressure.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.67 | Sell |
| 20-day SMA: | 14.59 | Sell |
| 50-day SMA: | 18.52 | Sell |
| 200-day SMA: | 23.07 | Sell |
| 8-day EMA: | 12.65 | Buy |
| 20-day EMA: | 9.17 | Buy |
| 50-day EMA: | 4.93 | Buy |
| 200-day EMA: | 1.45 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.59 | Buy |
| Relative Strength Index (14 RSI): | 35.94 | Sell |
| Chaikin Money Flow: | -382933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.67 - 16.29) | Sell |
| Bollinger Bands (100): | (16.77 - 25.49) | Sell |
Denali Therapeutics Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 12.79 while DNLI 8-day simple moving average is 13.67, which is a Sell signal.
-
The stock price of DNLI is 12.79 while Denali Therapeutics 20-day SMA is 14.59, which makes it a Sell.
-
Denali Therapeutics 50-day simple moving average is 18.52 while DNLI share price is 12.79, making it a Sell technically.
-
DNLI stock price is 12.79 and Denali Therapeutics 200-day simple moving average is 23.07, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
9
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a SellThe current Denali Therapeutics [DNLI] share price is $12.79. The Score for DNLI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
1.9B
Price in USD:
12.79
Share Volume:
1.5M
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
12.05
Sell
9
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?The Denali Therapeutics stock price is 12.79 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 12.79 while DNLI 8-day exponential moving average is 12.65, which is a Buy signal.
-
The stock price of DNLI is 12.79 while Denali Therapeutics 20-day EMA is 9.17, which makes it a Buy.
-
Denali Therapeutics 50-day exponential moving average is 4.93 while DNLI share price is 12.79, making it a Buy technically.
-
DNLI stock price is 12.79 and Denali Therapeutics 200-day simple moving average is 1.45, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.25 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is 3.59, suggesting Denali Therapeutics is a Buy
-
Denali Therapeutics Relative Strength Index (RSI) is 35.94, which suggest Denali Therapeutics is oversold
-
The Bollinger Bands (25) for Denali Therapeutics is (13.67 - 16.29), which suggest Denali Therapeutics is a Sell
-
The Bollinger Bands (100) for Denali Therapeutics is (16.77 - 25.49), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.